HEALIUS LIMITED — Share Issue/Capital Change 2021

Jul 8, 2021

ASX Announcement (ASX: HLS)

ASX Limited Market Announcements Office Exchange Centre Level 4, 20 Bridge Street Sydney NSW 2000

==> picture [138 x 29] intentionally omitted <==

HEALIUS LIMITED ACN 064 530 516 REGISTERED OFFICE: LEVEL 6 203 PACIFIC HIGHWAY ST LEONARDS NSW 2065 TEL: +61 2 9432 9400 FAX: +61 2 9432 9447

9 July 2021

Clarification of Appendix 2A lodged today – number of HLS ORD on issue

Healius Limited (“Healius”) wishes to clarify that the Appendix 2A online form lodged today does not account for ordinary shares bought back and cancelled since December 2020 under Healius’ continuing on-market buy-back.

As at today, the number of HLS ORD on issue, including the recently-issued ordinary shares which are the subject of the Appendix 2A, is 598,782,254 .

Healius confirms that the numbers of unquoted securities on issue reported in the Appendix 2A are correct.

ENDS

The release of this announcement has been authorised by the Group Company Secretary.

For over 30 years Healius has been one of Australia’s leading healthcare companies committed to supporting quality, affordable and accessible healthcare for all Australians. Today Healius has three main businesses – pathology, imaging, and day hospitals/IVF. Through its unique footprint of centres and 10,500 employees, Healius provides diagnostic services to consumers and their referring practitioners, as well as enabling a range of independent healthcare professionals to deliver patient care in partnership with Healius’ nurses and support staff.